Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

VINTAGE (Ventricular Intramyocardial Navigation for Tachycardia Ablation Guided by Electrograms) Using Commercial Off-The-Shelf (COTS) Catheters

Study ID: NCT06940752
Start Date: 2025-12-18
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

VINTAGE (Ventricular Intramyocardial Navigation for Tachycardia Ablation Guided by Electrograms)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease

Study ID: NCT07265258
Start Date: 2025-12-30
End Date: 2027-09-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

92

Intervention / Treatment

Teprotumumab N01

Methylprednisolone

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)

Study ID: NCT07225725
Start Date: 2026-01-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Community Health Support Specialist (CHSS) Navigation

Sponsor

University of Tennessee

Source: clinicaltrials.gov

Share:
Add to list

Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM

Study ID: NCT06661343
Start Date: 2026-02
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

C4 Program

C4 + 3MV Program

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

ACT-based Parenting Program for Caregivers of Children With Hearing Loss Post-cochlear: A Pilot Randomised Controlled Trial

Study ID: NCT07278947
Start Date: 2025-12-15
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

64

Intervention / Treatment

ACT-based parenting program+usual care

Usual care

Sponsor

Second Xiangya Hospital of Central South University

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging

Study ID: NCT06392347
Start Date: 2027-08
End Date: 2030-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment
Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Quit and Screen Project

Study ID: NCT06350643
Start Date: 2026-02-15
End Date: 2026-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Quit and Screen Project training

G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Study ID: NCT06980038
Start Date: 2026-08-21
End Date: 2027-11-24
Study Type

Interventional

Study Phase

Phase2

No. of Participants

44

Intervention / Treatment

Anti-CD40 Agonist Monoclonal Antibody CDX-1140

Biopsy Procedure

Biospecimen Collection

Cemiplimab

Computed Tomography

Positron Emission Tomography

Tumor Resection

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Healing ALS Registry Observational Study (HAROS)

Study ID: NCT07233148
Start Date: 2026-01-01
End Date: 2036-02-28
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Education about treatment options

Dietary Supplements: Vitamins, Minerals, Herbs, etc.

Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc.

Diet, various diets will be observed

Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapies

ALS medications and other medications

Physical and emotional support

Sponsor

Healing Advocates Registry and Ministry

Source: clinicaltrials.gov

Share:
Add to list

Clinnova-RD: A Prospective Cohort Study of Patients With Rheumatoid Diseases

Study ID: NCT06235684
Start Date: 2026-04-01
End Date: 2032-05-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Either newly diagnosed with a RD requiring initiation of therapy OR treatment change at the time of inclusion

Sponsor

Luxembourg Institute of Health

Source: clinicaltrials.gov

Share:
Add to list